Skip to Content

Clinical Trials Search Results

Showing 1-1 of 1

Sorted By:

  • NSABP B-52

    A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated with Neoadjuvant Therapy of Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab (TCHP) With or Without Estrogen Deprivation

Showing trial 1 of 1

Also in this Section